SEPTERNA ANNOUNCES SELECTION OF SEP-204 AS DEVELOPMENT CANDIDATE FOR GRAVES' DISEASE AND TED AND REPORTS PRECLINICAL DATA AT THE 2026 AMERICAN THYROID ASSOCIATION ANNUAL MEETING

Reuters · 1d ago

Please log in to view news